- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07674017
Effectiveness of MBT-C Among Foster Children
Effectiveness of Mentalization-Based Treatment on Emotion Regulation and Emotional Awareness Among Children in Foster Care
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Isfahan, Iran
- Isfahan Welfare Organization
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- having emotional and behavioral difficulties, diagnosed using the cutoff score of 14 or higher on the carer-report version of the Strengths and Difficulties Questionnaire (SDQ), including scores of 5 or higher on the Emotional Symptoms subscale and 3 or higher on the Conduct Problems subscale.
- Aged 7 to 12 years.
- Living with foster parents for at least 4 weeks
Exclusion Criteria:
- Presence of an intellectual disability.
- A diagnosed psychiatric disorder documented in the records of the Child Welfare Organization.
- Participating in other psychotherapeutic interventions.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Kontrolgruppe
|
|
|
Eksperimentel: MBT-C
|
MBT-C is a transdiagnostic, time-limited, and manualized psychotherapy for children, delivered with parallel parent sessions. The model emphasizes a predetermined number of sessions, a treatment calendar, and a focused case formulation. A clear therapeutic contract is established at the beginning with both parents and children, fostering collaboration, agency, and transparency which is a significant aspect of the mentalizing stance. While MBTC is designed to address multiple domains, including explicit mentalization, attention control, and relational capacities, these domains were considered supportive targets in the present study, as they contribute to strengthening children's emotion regulation. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Emotional awareness
Tidsramme: Baseline: One day before the first intervention session. Post-test: One day after the final intervention session. Follow-up: Two months after the final intervention session.
|
Emotional awareness is defined as the conscious ability to recognize, differentiate, and verbalize one's own emotions, while also identifying and interpreting the emotions of others, thereby supporting adaptive coping and psychological wellbeing.
It was measured using the Emotion Awareness Questionnaire (EAQ).
It is a 30-item self-report measure of emotional awareness comprising six subscales: Differentiating Emotions, Verbal Sharing of Emotions, Bodily Awareness of Emotions, Acting Out Emotions, Analysis of Emotions, and Awareness of Others' Emotions.
Subscale scores may be examined separately, and a total score can be calculated to reflect overall emotional awareness.
Total scores range from 30 to 90, with higher scores indicating greater emotional awareness.
|
Baseline: One day before the first intervention session. Post-test: One day after the final intervention session. Follow-up: Two months after the final intervention session.
|
|
Emotion regulation
Tidsramme: Baseline: One day before the first intervention session. Post-test: One day after the final intervention session. Follow-up: Two months after the final intervention session.
|
Emotion regulation refers to the internal and external processes through which individuals monitor, evaluate, and modify emotional experiences to achieve adaptive functioning.
It was measured using The Emotional Regulation Checklist (ERC).
This 24-item checklist is a caregiver-report measure designed to assess children's emotional expressiveness and regulation.
Respondents rate each item on a 4-point Likert scale, ranging from 1 (rarely/never) to 4 (almost always).
The ERC comprises two distinct subscales: Emotion Regulation (8 items; score range = 8-32) and Lability/Negativity (15 items; score range = 15-60).
Scores for each subscale can be interpreted independently, with higher scores on the Emotion Regulation subscale indicating stronger regulatory capacities and higher scores on the Lability/Negativity subscale reflecting greater emotional dysregulation.
|
Baseline: One day before the first intervention session. Post-test: One day after the final intervention session. Follow-up: Two months after the final intervention session.
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- IR.ARDAKAN.REC.1403.023
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Familiepleje
-
Xuzhou Medical UniversityIkke rekrutterer endnuIkke-invasiv CAR-T-celleovervågning | BCMA-målrettet PET-skanning | CAR-T-cellebiodistribution og -persistens | GMP-overensstemmende Radiopharmaka-præparation
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringCLL | SLL | CAR-T celleterapiKina
-
Duke UniversityNational Institutes of Health (NIH)RekrutteringHæmatopoietisk stamcelletransplantation | CAR-T celleterapiForenede Stater
-
Patrick C. Johnson, MDRekruttering
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
University Health Network, TorontoRekrutteringLymfom, der modtager CAR-T-terapiCanada
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.Ikke rekrutterer endnuAllogen, CAR-T, proteinsekvestrering, ikke-genredigeretKina
-
Ruijin HospitalAktiv, ikke rekrutterendeALL (akut B-lymfoblastisk leukæmi) | CAR-T celleterapiKina
Kliniske forsøg med Mentalization-based treatment for children
-
Stanford UniversityJohn & Marcia Goldman FoundationAfsluttetAutismespektrumforstyrrelse | AutismeForenede Stater
-
Stanford UniversityAnonymous DonorRekrutteringAutismespektrumforstyrrelse | Autisme | ASDForenede Stater
-
SangathAfsluttet